by | Jul 6, 2026 | Case, James Brett, Diamond, Michael
— Published Date: 7/7/2026
Value Proposition: This invention introduces a mucosal vaccine that can provide immunity against multiple Sarbecoviruses.
Technology Description
Researchers at Washington University in St. Louis have developed an adenoviral-vectored vaccine that can induce broad immunity…
by | Jun 12, 2026 | Lee, Jeongmin, Piston, David, Ustione, Alessandro
— Published date: 6/13/2026
Value Proposition: Novel glucagon regulator and therapeutic for diabetes
Technology Description
Researchers from the laboratory of Dr. David Piston at Washington University have discovered and isolated a peptide-based treatment from brown adipose tissue that normal…
by | May 19, 2026 | Diamond, Michael, Hunstad, David, Kuhn, Hunter, Ma, Hongming
— Published date: 5/20/2026
Value Proposition: Potential adjunctive therapy for E. coli pyelonephritis to mitigate the renal tissue damage associated with infection, thereby reducing renal scarring and other long-term complications of renal scarring.
Technology Description
Researchers at Washingt…
by | Feb 27, 2026 | Chakrabartty, Shantanu, Gupta, Prashant, Raman, Baranidharan, Singamaneni, Srikanth
— Published date: 2/28/2026
Value Proposition: Novel process that can improve the sensitivity and specificity of biohybrid chemical sensors.
Technology Description
Researchers at Washington University in St. Louis have developed a chemically enhanced nanoparticle structure that can react to l…
by | Jan 22, 2026 | Diamond, Michael, Fremont, Daved, Hui, Sean, Li, Pengfei
— Published date: 1/14/2026
Value Proposition: Entry receptors that bind directly to TBEV, promoting virus attachment to treat TBEV and other viruses.
Technology Description
Researchers at Washington University in St. Louis have developed LRP8 soluble decoy receptors (minimal domains-Fc fusion …